This is a preview of subscription content, log in via an institution to check access.
References
Artzt, K. and Jacob, F.: Absence of scrologically detectable H-2 on primitive teratocarcinoma cells in culture. Transplantation 17: 632–634, 1974
Avner, P.: Genetics of teratocarcinoma transplantation II. Transplantation 30: 185–190, 1980
Avner, P. and Simmler, M. C.: Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts. J. Reprod. Immunol. 4: 31–37, 1982
Avner, P. R., Dove, W. F., Dubois, P., Gaillard, J. A., Guenet, J.-L., Jacob, F., Jakob, H., and Shedlovsky, A.: The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3. Immunogenetics 7: 103–115, 1978
Edidin, M.: The appearance of cell surface antigens in the development of the mouse embryo: a study of cell surface differentiation In A. McLaren (ed.): Embryogenesis in Mammals, pp. 177–197, Ciba Foundation Symp. 40, Elsevier, Amsterdam, 1976
Isa, A. M.: Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo. Transplantation 2: 195–198, 1976
Klein, J.: Biology of the Mouse Histocompatibility — 2 Complex, Springer-Verlag, New York, 1975
Levine, A. J. and Teresky, A. K.: Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles. Immunogenetics 13: 405–412, 1981
McKenzie, I. F. C., Morgan, G. M., Sandrin, M. S., Michaelides, M. M., Melvold, R. W., and, Kohn, H. I.: B6.C-H-bm12: A new H-2 mutation in the I region in the mouse. J. Exp. Med. 150: 1323–1338, 1979
Melvold, R. W., Kohn, H. I., and Dunn, G. R.: History and genealogy of the H-2K b mutants from the C57BL/6Kh colony. Immunogenetics 15: 177–185, 1982
Michaelson, J.: Genetics of beta-2-microglobulin in the mouse. Immunogenetics 17: 219–259, 1983
Ostrand-Rosenberg, S.: Mouse teratocarcinoma 402AX growth in syngeneic and allogeneic hosts. In W. Hildemann (ed.): Frontiers in Immunogenetics, pp. 141–156, Elsevier North Holland, New York, 1981
Ostrand-Rosenberg, S. and Cohan, V. L.: H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice. J. Immunol. 126: 2190–2193, 1981
Ostrand-Rosenberg, S. and Cohn, A.: H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 78: 7106–7110, 1981
Ostrand-Rosenberg, S., Rider, T. M., and Twarowski, A.: Susceptibility of allogenic mice to teratocarcinoma 402AX. Immunogenetics 10: 607–612, 1980
Ostrand-Rosenberg, S., Cohn, A., Sandoz, J. W., Schwartzman, M., and McCarthy, C.: Teratocarcinoma Stem Cells Cold Spring Harbor Conf Cell Prolif. Vol. 10, pp. 519–529, 1983
Sachs, D. H., Arn, J. S., and Hansen, T. H.: Two new recombinant H-2 haplotypes one of which juxtaposes Kb and Ik alleles. J. Immunol. 123: 1965–1969, 1979
Shedlovsky, A., Clipson, L. J., VandeBerg, J. L., and Dove, W. F.: Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2. Immunogenetics 13: 413–419, 1981
Siegler, E. L., Tick, N., Teresky, A. K., Rosenstraus, M., and Levine, A. J.: Teratocarcinoma transplantation rejection loci: an H-2-linked tumor rejection locus. Immunogenetics 9: 207–220, 1979
Simmler, M. C., Avner, P., Levy, J. P.: Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses. Immunogenetics 16: 349–354, 1982
Stevens, L. C.: Studies on transplantable testicular teratomas of strain 129 mice. J. Natl. Cancer Inst. 20: 1257–1275, 1958
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ostrand-Rosenberg, S., McCarthy, C. Resistance to murine 402ax teratocarcinoma: Regulation by H-21A and H-3 to H-13 region genes. Immunogenetics 19, 77–82 (1984). https://doi.org/10.1007/BF00364477
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00364477